We subsequently classified samples with PTEN copy number loss or point mutation as PTEN mutant breast cancers, and samples with PTEN copy number gain or without any reported PTEN copy number alterations or point mutations as PTEN wildtype breast cancers. Here, PTEN is linked to breast cancer.